The European Code Against Cancer, 4th edition
Translations into other languages coming soon.
Latest evidence, myths, and controversies
This second set of modules presents some of the latest evidence that has emerged since the 4th edition of the European Code Against Cancer was published in 2014, and tackles some myths and controversies related to the topics addressed by the 12 recommendations of the European Code Against Cancer, 4th edition.
Use the self-paced modules to learn about further evidence beyond the European Code Against Cancer, 4th edition, and to find out how to differentiate between myths and reality.
Modules coming soon
These modules were created thanks to the Cancer Prevention Europe (CPE) partners (cancerpreventioneurope.iarc.fr/consortium), in particular the World Cancer Research Fund International (wcrf.org), and developed by experts from all the CPE partner institutions and the International Agency for Research on Cancer.
The translations of these modules were provided by:
- The French National Cancer Institute (INCa), which specializes in comprehensive cancer control and research (e-cancer.fr), and the Centre Léon Bérard (centreleonberard.fr), which is dedicated to comprehensive cancer care, prevention, and research.
- The Asociación Española Contra el Cáncer (AECC) (aecc.es), which leads the efforts of Spanish society to reduce the impact of cancer and to improve people’s lives.
- The Association of European Cancer Leagues (ECL) (europeancancerleagues.org), which provides an exclusive platform for members to collaborate with their international peers, primarily in the areas of cancer prevention, tobacco control, access to medicines, and patient support. The ECL, with the support of grant agreement 101015525 from the Third European Union Health Programme 2014–2020, co-financed the translation into Hungarian with the Hungarian League Against Cancer (rakliga.hu) and the translation into Polish with the Maria Skłodowska-Curie – National Research Institute of Oncology (pib-nio.pl).